Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTSCIM2)

• DTT Name: Extracellular lysophospholipase D (E-NPP2) DTT Info
• Gene Name: ENPP2

Molecule-Related Drug & Molecule List

1 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Cudetaxestat	DMYLDN9	Idiopathic pulmonary fibrosis	CB03.4	Phase 2	[1]

26 Patented Agent(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Complex heterocyclic compound 1	DMWYJF6	Inflammation	1A00-CA43.1	Patented	[2]
Dihydropyrido pyrimidine derivative 1	DMSTC9Z	N. A.	N. A.	Patented	[2]
Heteroaromatic ring derivative 1	DMI732U	N. A.	N. A.	Patented	[2]
Heteroaromatic ring derivative 2	DM5YD4W	N. A.	N. A.	Patented	[2]
Heteroaromatic ring derivative 3	DMKJL5T	N. A.	N. A.	Patented	[2]
Heteroaromatic ring derivative 4	DM9IL5Q	N. A.	N. A.	Patented	[2]
Imidazopyrimidinone derivative 1	DMWN17V	N. A.	N. A.	Patented	[2]
Octahydro-pyrrolo[3,4-c]-pyrrole derivative 1	DM0ECWR	N. A.	N. A.	Patented	[2]
Piperazine derivative 8	DM1XUVB	N. A.	N. A.	Patented	[2]
PMID28447479-Compound-10	DMA7OEF	N. A.	N. A.	Patented	[2]
PMID28447479-Compound-11	DMOYMWZ	N. A.	N. A.	Patented	[2]
PMID28447479-Compound-14	DMA91X2	N. A.	N. A.	Patented	[2]
PMID28447479-Compound-20	DMWSL5G	N. A.	N. A.	Patented	[2]
PMID28447479-Compound-21	DM8PET6	N. A.	N. A.	Patented	[2]
PMID28447479-Compound-22	DMRCM1O	N. A.	N. A.	Patented	[2]
PMID28447479-Compound-23	DMM0BVE	N. A.	N. A.	Patented	[2]
PMID28447479-Compound-24	DMDOVIZ	N. A.	N. A.	Patented	[2]
PMID28447479-Compound-26	DMJZSWF	N. A.	N. A.	Patented	[2]
PMID28447479-Compound-27	DMVZPIO	N. A.	N. A.	Patented	[2]
PMID28447479-Compound-4	DMUBM1Y	N. A.	N. A.	Patented	[2]
Pyrazole derivative 87	DMGZUAY	N. A.	N. A.	Patented	[2]
Pyrazolo[3,4-c]pyridine derivative 1	DMQHCDZ	N. A.	N. A.	Patented	[2]
Pyridine and pyrimidine derivative 1	DMGEYJW	Fibrosis	GA14-GC01	Patented	[2]
Pyrimidinone derivative 5	DMLFY57	N. A.	N. A.	Patented	[2]
Tetra-hydro-carboline derivative 1	DM5MVLG	N. A.	N. A.	Patented	[2]
Tetra-hydro-carboline derivative 2	DMXTL7V	N. A.	N. A.	Patented	[2]

References

• [1] An updated patent review of autotaxin inhibitors (2017-present). Expert Opin Ther Pat. 2021 May;31(5):421-434.
• [2] Autotaxin inhibitors: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Jul;27(7):815-829.